Cargando…

Antibiotic resistance: Evaluation of levofloxacin treatment in acute respiratory tract infections cases at the Tasikmalaya City Health Center, Indonesia

Acute respiratory tract infections (ARTIs) are an acute inflammation of the upper and lower respiratory tract caused by the infection of microorganisms or bacteria, viruses, without or accompanied by inflammation of the lung parenchyma. The use of antibiotics is one way to treat respiratory diseases...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramdhani, Danni, Azizah, Shinta Nur, Kusuma, Sri Agung Fitri, Sediana, Dede
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574731/
https://www.ncbi.nlm.nih.gov/pubmed/33102193
http://dx.doi.org/10.4103/japtr.JAPTR_17_20
_version_ 1783597683545473024
author Ramdhani, Danni
Azizah, Shinta Nur
Kusuma, Sri Agung Fitri
Sediana, Dede
author_facet Ramdhani, Danni
Azizah, Shinta Nur
Kusuma, Sri Agung Fitri
Sediana, Dede
author_sort Ramdhani, Danni
collection PubMed
description Acute respiratory tract infections (ARTIs) are an acute inflammation of the upper and lower respiratory tract caused by the infection of microorganisms or bacteria, viruses, without or accompanied by inflammation of the lung parenchyma. The use of antibiotics is one way to treat respiratory diseases. This study aims to determine the level of resistance of levofloxacin antibiotics to clinical isolates from ARTIs patients at the Tasikmalaya Health Center, Indonesia. The stages of the research included rejuvenation of clinical single isolates from ARTIs patients, identification of bacteria, and antibiotic resistance testing using the paper-disc method. The results of resistance tests from 142 single clinical isolates of acute respiratory infections showed that levofloxacin antibiotics had high levels of resistance of 50.0%, 30.95% of resistance with intermediate levels, and 19.04% were still sensitive. Bacterial identification test results showed bacteria that have been resistant to levofloxacin are from the genus Haemophillus, Streptococcus, Corynebacterium, Staphylococcus, and Bordetella. Treatment of ARTIs with the antibiotic levofloxacin shows that there has been a relatively large resistance, where the results of the identification of all bacteria showed the bacteria that cause ARTIs.
format Online
Article
Text
id pubmed-7574731
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-75747312020-10-22 Antibiotic resistance: Evaluation of levofloxacin treatment in acute respiratory tract infections cases at the Tasikmalaya City Health Center, Indonesia Ramdhani, Danni Azizah, Shinta Nur Kusuma, Sri Agung Fitri Sediana, Dede J Adv Pharm Technol Res Original Article Acute respiratory tract infections (ARTIs) are an acute inflammation of the upper and lower respiratory tract caused by the infection of microorganisms or bacteria, viruses, without or accompanied by inflammation of the lung parenchyma. The use of antibiotics is one way to treat respiratory diseases. This study aims to determine the level of resistance of levofloxacin antibiotics to clinical isolates from ARTIs patients at the Tasikmalaya Health Center, Indonesia. The stages of the research included rejuvenation of clinical single isolates from ARTIs patients, identification of bacteria, and antibiotic resistance testing using the paper-disc method. The results of resistance tests from 142 single clinical isolates of acute respiratory infections showed that levofloxacin antibiotics had high levels of resistance of 50.0%, 30.95% of resistance with intermediate levels, and 19.04% were still sensitive. Bacterial identification test results showed bacteria that have been resistant to levofloxacin are from the genus Haemophillus, Streptococcus, Corynebacterium, Staphylococcus, and Bordetella. Treatment of ARTIs with the antibiotic levofloxacin shows that there has been a relatively large resistance, where the results of the identification of all bacteria showed the bacteria that cause ARTIs. Wolters Kluwer - Medknow 2020 2020-07-14 /pmc/articles/PMC7574731/ /pubmed/33102193 http://dx.doi.org/10.4103/japtr.JAPTR_17_20 Text en Copyright: © 2020 Journal of Advanced Pharmaceutical Technology & Research http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Ramdhani, Danni
Azizah, Shinta Nur
Kusuma, Sri Agung Fitri
Sediana, Dede
Antibiotic resistance: Evaluation of levofloxacin treatment in acute respiratory tract infections cases at the Tasikmalaya City Health Center, Indonesia
title Antibiotic resistance: Evaluation of levofloxacin treatment in acute respiratory tract infections cases at the Tasikmalaya City Health Center, Indonesia
title_full Antibiotic resistance: Evaluation of levofloxacin treatment in acute respiratory tract infections cases at the Tasikmalaya City Health Center, Indonesia
title_fullStr Antibiotic resistance: Evaluation of levofloxacin treatment in acute respiratory tract infections cases at the Tasikmalaya City Health Center, Indonesia
title_full_unstemmed Antibiotic resistance: Evaluation of levofloxacin treatment in acute respiratory tract infections cases at the Tasikmalaya City Health Center, Indonesia
title_short Antibiotic resistance: Evaluation of levofloxacin treatment in acute respiratory tract infections cases at the Tasikmalaya City Health Center, Indonesia
title_sort antibiotic resistance: evaluation of levofloxacin treatment in acute respiratory tract infections cases at the tasikmalaya city health center, indonesia
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574731/
https://www.ncbi.nlm.nih.gov/pubmed/33102193
http://dx.doi.org/10.4103/japtr.JAPTR_17_20
work_keys_str_mv AT ramdhanidanni antibioticresistanceevaluationoflevofloxacintreatmentinacuterespiratorytractinfectionscasesatthetasikmalayacityhealthcenterindonesia
AT azizahshintanur antibioticresistanceevaluationoflevofloxacintreatmentinacuterespiratorytractinfectionscasesatthetasikmalayacityhealthcenterindonesia
AT kusumasriagungfitri antibioticresistanceevaluationoflevofloxacintreatmentinacuterespiratorytractinfectionscasesatthetasikmalayacityhealthcenterindonesia
AT sedianadede antibioticresistanceevaluationoflevofloxacintreatmentinacuterespiratorytractinfectionscasesatthetasikmalayacityhealthcenterindonesia